Skip to content

Clinical trial on the safety and effectiveness of absorbable surgical barbed suture for surgical incision closure

Clinical trial on the safety and effectiveness of absorbable surgical barbed suture for surgical incision closure

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098758
Enrollment
Unknown
Registered
2025-03-13
Start date
2022-06-22
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental group:Surgical incision suturing is performed using absorbable surgical barbed suture produced by Jianshi Medical Surgical Instruments (Wuxi) Co., Ltd
Control group:Surgical incision suturing is performed using absorbable surgical sutures produced by Johnson&Johnson (Shanghai) Medical Equipment Co., Ltd

Sponsors

The Pearl River Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.The subject is 18 years old or above, with no gender restrictions; 2.Subjects who require intradermal suture of surgical incision; 3.The subjects or their legal representatives are able to understand the research purpose and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Subjects with non stage I suture incisions; 2.At any time before surgery, plasma glucose levels should be greater than 11.1mmol/L; 3.Subjects with systemic or local skin diseases near the surgical incision that may affect the evaluation of the surgical incision (including patients with scar constitution, herpes, and other skin diseases); 4.Patients with sepsis and/or systemic inflammatory response syndrome (SIRS) (diagnostic criteria for sepsis: significantly elevated total peripheral blood white blood cell count, reaching 10-30 × 10?/L; diagnostic criteria for systemic inflammatory response syndrome: body temperature>38.5 ° C, pathogen causing infection identified); 5.Pregnant and lactating women, those who plan to conceive during the trial period; 6.Researchers believe that individuals who are not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Grade A wound healing rate ;

Secondary

MeasureTime frame
Infection rate of superficial tissue in incisions;Pain Visual Simulation Score;Performance evaluation of instrument operation;

Countries

China

Contacts

Public ContactCui Chunhui

The Pearl River Hospital of Southern Medical University

drcuich@163.com+86 1357054188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026